Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Has Found A Path To Profitability

By Yahoo! Finance | Jul 24, 2024 at 07:59 AM EST

Agios Pharmaceuticals, Inc. is a biopharmaceutical company focusing on cellular metabolism, aiming for profitability in 2024. Analysts predict a break-even by 2023, with a manageable 14% growth rate. The company's debt-free status reduces investment risk.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.